Replies to post #398744 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Get it right. Blarcamesine reduces chances of falling.

Interesting that those on placebo had a higher rate of falls than those on drug.
Yes, that is interesting, isn't it?

Check the data presented on page 25 here:
https://www.investorvillage.com/uploads/86653/files/CTAD_Slide_Deck.pdf

In the placebo arm of the study (161 people), a total of 16 were reported to have fallen during the study. That was 9.9% of the people in the placebo arm (who got no blarcamesine).

Over in the blarcamesine-treated arm of the study there were 301 people, of which 21 were reported as falling during the study. That's 7.0% of the participants.

The straight facts: 9.9% of the study participants not taking any blarcamesine had falls. Of those on the drug, only 7.0% fell. No other way to interpret this. Blarcamesine reduced the chances of falling.